Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05094336
Title	AMG 193, Methylthioadenosine (MTA) Cooperative Protein Arginine Methyltransferase 5 (PRMT5) Inhibitor, Alone and in Combination With Docetaxel in Advanced Methylthioadenosine Phosphorylase (MTAP)-Null Solid Tumors (MTAP)
Recruitment	Recruiting
Gender	both
Phase	Phase Ib/II
Variant Requirements	Yes
Sponsors	Amgen
Indications	lung non-small cell carcinoma pancreatic adenocarcinoma Advanced Solid Tumor biliary tract cancer head and neck squamous cell carcinoma
Therapies	AMG193 AMG193 + Docetaxel
Age Groups:	adult \| senior
Covered Countries	USA \| FRA \| DEU \| CAN \| BEL \| AUT \| AUS